May 17, 2013

Women & Alzheimer's: SeXX Does Matter - Dr. Jill Goldstein

Thumbnail

Women & Alzheimer's: SeXX Does Matter - Dr. Jill Goldstein

About This Episode

Women are two times more likely to die from Alzheimer’s disease. Can research focused on sex differences tell us why? And can it lead us to the effective prevention and treatment of Alzheimer’s?

Dr. Jill Goldstein, Professor of Psychiatry and Medicine at Harvard Medical School and Director of Research at the Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital, discussed this topic and answered questions.

This call was presented by WomenAgainstAlzheimer's. At the end of the call, Meryl Comer described this new network as well as the 2013 Geoffrey Beene Global NeuroDiscovery Challenge - focused on sex-based differences in Alzheimer's with over $100,000 in prizes.

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW